Edward G. Galante
Edward G. Galante's purchase track record
Edward G. Galante has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/14/2025 | CE | $99K | -6.2% | +38.1% | +5.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Clean Harbors Gets Higher Price Targets from Citi and TD Cowen. Citigroup and TD Cowen both maintained their positive ratings on Clean Harbors, raising their price targets to $378 and $390, respectively. These updates occur as the company releases its 2026 Sustainability Report and faces questions about its debt and deal funding. The stock currently trades near its 52-week high, with an average analyst target of $359.93.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Marathon Petroleum: Analyst Fair Value Boost Amid Market Declines. Recent analysis highlights that analysts have lifted refining assumptions, boosting the fair value estimate for Marathon Petroleum. At the same time, the company's stock has declined while the broader market improved, prompting comparisons with peers like Delek US. These reports also discuss the impact of diesel market dynamics on the company's refining margins and its potential as a defensive hedge in the current energy environment.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
RBC Lowers Linde Price Target to $549 Amid Earnings Preview. RBC Capital has maintained its Outperform rating on Linde but lowered its price target to $549. This move comes as investors prepare for the company's upcoming quarterly earnings report. The stock is currently trading near its 52-week high, with an average analyst target of $544.15 suggesting limited upside from current levels.
Transaction History
| CE | ▲ Buy | Grant | 1,930 | $0 | 8/10/2026 | View on chart |
| CLH | ▲ Buy | Grant | 652 | $0 | 5/20/2026 | View on chart |
| CE | ▲ Buy | Grant | 4,676 | $0 | 5/11/2026 | View on chart |
| CE | ▲ Buy | Open Market | 2,400 | $99K | 8/14/2025 | View on chart |
| CLH | ▲ Buy | Grant | 789 | $0 | 5/21/2025 | View on chart |
| CE | ▲ Buy | Grant | 4,090 | $0 | 5/9/2025 | View on chart |
| MPC | ▲ Buy | Grant | 94 | $0 | 4/1/2025 | View on chart |
| MPC | ▲ Buy | Grant | 294 | $0 | 1/2/2025 | View on chart |
| MPC | ▲ Buy | Grant | 251 | $0 | 10/1/2024 | View on chart |
| MPC | ▲ Buy | Grant | 225 | $0 | 7/1/2024 | View on chart |
| CLH | ▲ Buy | Grant | 836 | $0 | 5/22/2024 | View on chart |
| CE | ▲ Buy | Grant | 1,114 | $175K | 5/15/2024 | View on chart |
| MPC | ▲ Buy | Grant | 193 | $0 | 4/1/2024 | View on chart |
| MPC | ▲ Buy | Grant | 258 | $0 | 1/2/2024 | View on chart |
| MPC | ▲ Buy | Grant | 262 | $0 | 10/2/2023 | View on chart |
| MPC | ▲ Buy | Grant | 335 | $0 | 7/3/2023 | View on chart |
| CLH | ▲ Buy | Grant | 1,148 | $0 | 5/24/2023 | View on chart |
| CE | ▲ Buy | Grant | 1,777 | $175K | 5/12/2023 | View on chart |
| MPC | ▲ Buy | Grant | 290 | $0 | 4/3/2023 | View on chart |
| LIN | ▲ Buy | Option Exercise | 611 | $0 | 3/8/2023 | View on chart |
| MPC | ▲ Buy | Grant | 355 | $0 | 1/3/2023 | View on chart |
| MPC | ▲ Buy | Grant | 383 | $0 | 10/3/2022 | View on chart |
| CLH | ▼ Sell | Gift | 4,710 | $0 | 8/12/2022 | View on chart |
| MPC | ▲ Buy | Grant | 466 | $0 | 7/1/2022 | View on chart |
| CLH | ▲ Buy | Grant | 1,849 | $0 | 5/25/2022 | View on chart |
| CE | ▲ Buy | Grant | 1,098 | $160K | 5/3/2022 | View on chart |
| MPC | ▲ Buy | Grant | 464 | $0 | 4/1/2022 | View on chart |
| LIN | ▲ Buy | Option Exercise | 518 | $0 | 2/23/2022 | View on chart |
| MPC | ▲ Buy | Grant | 600 | $0 | 1/3/2022 | View on chart |
| CLH | ▲ Buy | Grant | 257 | $0 | 1/3/2022 | View on chart |
| MPC | ▲ Buy | Grant | 619 | $0 | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Celanese Sets Q3 Earnings Call for November 3, 2026
Celanese has announced it will hold its third-quarter earnings conference call on November 3, 2026. The company is also mentioned in a new industry report on thermo compression forming, which highlights its role in advanced manufacturing. With the stock trading near its 52-week low, upcoming earnings results may provide clarity on the company's performance.
Celanese Sets Q3 Earnings Call for November 3, 2026. Celanese has announced it will hold its third-quarter earnings conference call on November 3, 2026. The company is also mentioned in a new industry report on thermo compression forming, which highlights its role in advanced manufacturing. With the stock trading near its 52-week low, upcoming earnings results may provide clarity on the company's performance.